ABSTRACT BACKGROUND: Developmental dysplasia of the hip (DDH) encompasses a
broad spectrum of hip pathologies, including femoral or acetabular dysplasia, hip instability …

Methods Children referred to US examination for a healthy child screening program,
according to the health policy of our country, are included in the current prospective study …

Objectives To evaluate the accuracy of measurement of the pubofemoral distance (PFD) for
the diagnosis of developmental dysplasia of the hip (DDH), using the Graf method as the …

The pubo-femoral distance (PFD) has been suggested as an ultrasound screening tool for
developmental dysplasia of the hip (DDH). The aim of this study was to examine if midwives …

Background and purpose—Current selective screening algorithms for developmental
dysplasia of the hip (DDH) are insufficient. Universal screening programs have been …

Objectives Ultrasound (US) is important for diagnosing infant developmental dysplasia of the
hip (DDH). However, the accuracy of the diagnosis depends heavily on expertise. We aimed …

Background/Objectives: The prevalence of developmental hip dysplasia is estimated to be
0.1–2 per 1000 infants. Hip imaging by ultrasonography is considered to be the gold …

Aims The present study seeks to investigate the correlation of pubofemoral distances (PFD)
to α angles, and hip displaceability status, defined as femoral head coverage (FHC) or FHC …

Objective To compare pubo-femoral distance (PFD) in normal hips and those treated for
developmental dysplasia of the hip (DDH) and to investigate the value of ultrasonography …

Background Measuring the pubofemoral distance (PFD) is important for evaluating the
effectiveness of hip reduction in the treatment of developmental dysplasia of the hip (DDH) …